Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.6722 USD 0.13%
Market Cap: 15.8m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Gross Margin
Trinity Biotech PLC

34.3%
Current
35%
Average
47.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
34.3%
=
Gross Profit
20.1m
/
Revenue
58.7m

Gross Margin Across Competitors

Country IE
Market Cap 15.4m USD
Gross Margin
34%
Country US
Market Cap 201.2B USD
Gross Margin
56%
Country US
Market Cap 183.9B USD
Gross Margin
67%
Country US
Market Cap 140.5B USD
Gross Margin
64%
Country US
Market Cap 128.1B USD
Gross Margin
69%
Country IE
Market Cap 113.4B USD
Gross Margin
66%
Country US
Market Cap 67.4B USD
Gross Margin
45%
Country DE
Market Cap 58.8B EUR
Gross Margin
38%
Country CN
Market Cap 340.9B CNY
Gross Margin
65%
Country US
Market Cap 40B USD
Gross Margin N/A
Country US
Market Cap 39.9B USD
Gross Margin
41%

Profitability Report

View the profitability report to see the full profitability analysis for Trinity Biotech PLC.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
34.3%
=
Gross Profit
20.1m
/
Revenue
58.7m
What is the Gross Margin of Trinity Biotech PLC?

Based on Trinity Biotech PLC's most recent financial statements, the company has Gross Margin of 34.3%.